| P50 | author | Kai Kaarniranta | Q30512455 |
| | Hannu Uusitalo | Q42539934 |
| P2093 | author name string | Jari Leppälä | |
| | Matti Kontkanen | |
| P2860 | cites work | Basal cell carcinomas of the eyelids | Q36085511 |
| | Basal cell carcinoma of the eyelid and periocular skin | Q40778092 |
| | Imiquimod in basal cell carcinoma: how does it work? | Q42452726 |
| | Basal cell carcinoma on the eyelids: own experience | Q42456959 |
| | Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies | Q42460540 |
| | Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. | Q42488508 |
| | Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial | Q42503139 |
| | Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study | Q42525212 |
| | Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens | Q42525863 |
| | Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion | Q42528185 |
| | Imiquimod: a cytokine inducer | Q44104411 |
| | Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod | Q44241584 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 566-568 | |
| P577 | publication date | 2007-03-22 | |
| P1433 | published in | Acta Ophthalmologica | Q15716498 |
| P1476 | title | Imiquimod in the treatment of eyelid basal cell carcinoma. | |
| P478 | volume | 85 | |